These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 25812756)
61. Pretreatment of endothelial progenitor cells with osteopontin enhances cell therapy for peripheral vascular disease. Vaughan EE; Liew A; Mashayekhi K; Dockery P; McDermott J; Kealy B; Flynn A; Duffy A; Coleman C; O'Regan A; Barry FP; O'Brien T Cell Transplant; 2012; 21(6):1095-107. PubMed ID: 22304991 [TBL] [Abstract][Full Text] [Related]
62. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. Matoba S; Tatsumi T; Murohara T; Imaizumi T; Katsuda Y; Ito M; Saito Y; Uemura S; Suzuki H; Fukumoto S; Yamamoto Y; Onodera R; Teramukai S; Fukushima M; Matsubara H; Am Heart J; 2008 Nov; 156(5):1010-8. PubMed ID: 19061721 [TBL] [Abstract][Full Text] [Related]
63. Angiogenic growth factors in the treatment of peripheral arterial disease. Mikroulis D; Papanas N; Maltezos E; Bougioukas G Curr Vasc Pharmacol; 2007 Jul; 5(3):195-209. PubMed ID: 17627563 [TBL] [Abstract][Full Text] [Related]
64. Therapeutic angiogenesis by gene transfer in critical limb and myocardial ischemia. Schratzberger P; Kirchmair R; Vale PR; Losordo DW Curr Pharm Des; 2003; 9(13):1041-7. PubMed ID: 12678856 [TBL] [Abstract][Full Text] [Related]
65. [Therapeutic angiogenesis using gene transfer and stem cell therapy in peripheral artery disease]. Nikol S Dtsch Med Wochenschr; 2011 Apr; 136(14):672-4. PubMed ID: 21448824 [TBL] [Abstract][Full Text] [Related]
67. Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies. Qadura M; Terenzi DC; Verma S; Al-Omran M; Hess DA Stem Cells; 2018 Feb; 36(2):161-171. PubMed ID: 29226477 [TBL] [Abstract][Full Text] [Related]
68. Therapeutic angiogenesis using zinc oxide nanoflowers for the treatment of hind limb ischemia in a rat model. Barui AK; Nethi SK; Basuthakur P; Jhelum P; Bollu VS; Reddy BR; Chakravarty S; Patra CR Biomed Mater; 2021 Mar; 16(4):. PubMed ID: 33657534 [TBL] [Abstract][Full Text] [Related]
69. Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Nikol S; Baumgartner I; Van Belle E; Diehm C; Visoná A; Capogrossi MC; Ferreira-Maldent N; Gallino A; Wyatt MG; Wijesinghe LD; Fusari M; Stephan D; Emmerich J; Pompilio G; Vermassen F; Pham E; Grek V; Coleman M; Meyer F; Mol Ther; 2008 May; 16(5):972-8. PubMed ID: 18388929 [TBL] [Abstract][Full Text] [Related]
70. [Enhancement of angiogenesis as the basis of reparative morphogenesis in ischemic myocardial lesion]. Potapov IV; Kirillov IA Vestn Ross Akad Med Nauk; 2007; (9):3-9. PubMed ID: 18030711 [TBL] [Abstract][Full Text] [Related]
71. [Medical treatment of critical leg ischemia: current status and future perspectives of gene and cell therapy]. Emmerich J; Fiessinger JN Bull Acad Natl Med; 2006 Mar; 190(3):667-80; discussion 680-1, 683-4. PubMed ID: 17140102 [TBL] [Abstract][Full Text] [Related]
72. Gene transfer to induce angiogenesis in myocardial and limb ischaemia. Laham RJ; Mannam A; Post MJ; Sellke F Expert Opin Biol Ther; 2001 Nov; 1(6):985-94. PubMed ID: 11728230 [TBL] [Abstract][Full Text] [Related]
73. Meta-analysis of randomized, controlled clinical trials in angiogenesis: gene and cell therapy in peripheral arterial disease. De Haro J; Acin F; Lopez-Quintana A; Florez A; Martinez-Aguilar E; Varela C Heart Vessels; 2009 Sep; 24(5):321-8. PubMed ID: 19784813 [TBL] [Abstract][Full Text] [Related]
74. Gene therapy and cell-based therapies for therapeutic angiogenesis in peripheral artery disease. Shimamura M; Nakagami H; Koriyama H; Morishita R Biomed Res Int; 2013; 2013():186215. PubMed ID: 24294599 [TBL] [Abstract][Full Text] [Related]
75. Therapeutic angiogenesis using autologous adipose-derived regenerative cells in patients with critical limb ischaemia in Japan: a clinical pilot study. Katagiri T; Kondo K; Shibata R; Hayashida R; Shintani S; Yamaguchi S; Shimizu Y; Unno K; Kikuchi R; Kodama A; Takanari K; Kamei Y; Komori K; Murohara T Sci Rep; 2020 Sep; 10(1):16045. PubMed ID: 32994527 [TBL] [Abstract][Full Text] [Related]
76. Allogeneic transplantation of programmable cells of monocytic origin (PCMO) improves angiogenesis and tissue recovery in critical limb ischemia (CLI): a translational approach. Berndt R; Hummitzsch L; Heß K; Albrecht M; Zitta K; Rusch R; Sarras B; Bayer A; Cremer J; Faendrich F; Groß J Stem Cell Res Ther; 2018 Apr; 9(1):117. PubMed ID: 29703251 [TBL] [Abstract][Full Text] [Related]